Esobert®

Therapeutic Segment: Anti-Ulcerant

Generic Name: Esomeprazole

Therapeutic Indication: Esobert (Esomeprazole) is indicated for:

  • Treatment of Gastroesophageal Reflux Disease (GERD)
    Healing of Erosive Esophagitis
    Maintenance of Healing of Erosive Esophagitis
    Symptomatic Gastroesophageal Reflux Disease
  • Risk Reduction of NSAID-Associated Gastric Ulcer
  • H. Pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence
    As a triple therapy (Esomeprazole plus amoxicillin and clarithromycin) is indicated for the treatment of patients With H. pylori infection and duodenal ulcer disease to eradicate H. Pylori Eradication of H. Pylori has been shown to reduce the risk of duodenal ulcer recurrence.
    Note : : In patients who fail therapy susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not possible, alternative antimicrobial therapy should be instituted Maintenance of Healing of Erosive Esophagitis
    Symptomatic Gastroesophageal Reflux Disease
  • Pathological Hyper secretory Conditions including Zollinger Ellison Syndrome

Available as:

Capsules
  • 20MG
  • 40MG
Our Featured Brands